Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01209962 · ClinicalTrials.gov registry record
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT01209962: Completed study, sponsored by University of Michigan Rogel Cancer Center.
NCT01209962 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01209962 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health factors. The goals of therapy are to reduce or eliminate the cancer cells, but without serious damage to normal cells. Investigators at The University of Michigan are conducting a research project, to see if treatment effects on an individual patient's cancer cells can be detected early by new imaging tests in patients with resectable pancreatic cancer undergoing neoadjuvant chemoradiotherapy.
Primary Outcome
The goal is to develop a functional imaging method that would be a better predictor of pathological response than the current CT standard. Diffusion MRI has the potential to measure early cellular changes that occur in response to successful therapies, such as chemoradiation, and has been demonstrated to be an early predictor not only of therapeutic response, but also of overall survival for other malignancies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-05 |
| Est. Completion | 2015-05-26 |
What the finished NCT01209962 record still lists
NCT01209962 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01209962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01209962 about?
NCT01209962 is a clinical study titled "A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response". Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health factors. The goals of therapy are to reduce or eliminate the cancer cells, but without serious damage to normal ce...
What is the current status of trial NCT01209962?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-05. Estimated completion is 2015-05-26.
Who is sponsoring clinical trial NCT01209962?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia